Tirzepatide

"Significant Weight Loss: Clinical trials (SURMOUNT program) showed that weekly injections (5 mg to 15 mg) resulted in a 15% to 21% reduction in body weight over 72 weeks.

Improved Glycemic Control: It is highly effective at lowering HbA1c and managing blood sugar levels, often outperforming other diabetes medications.

Appetite Regulation: By mimicking GIP and GLP-1 hormones, it slows gastric emptying, increases feelings of fullness, and reduces food cravings.

Cardiovascular and Metabolic Health: It has been shown to reduce systolic and diastolic blood pressure, improve lipid profiles, and reduce markers of inflammation.

Heart Failure Management: Trials indicate that it reduces the risk of worsening heart failure events or death from cardiovascular causes in patients with obesity.

Treatment of Obesity-Related Conditions: FDA approved for weight loss under the brand name Zepbound, it is also used for chronic weight management and treating obstructive sleep apnea (OSA)."